Similar articles

• [Clinical experimentation with Cardiocap in subjects with coronary disease with coronary insufficiency].

  Marignani A, Martelli A, Piana G. Marignani A, et al. Minerva Cardioangiol. 1973 Sep;21(9):629-35. Minerva Cardioangiol. 1973. PMID: 4745005 Italian. No abstract available.
• [Therapeutic and prophylactic effectiveness of carbochromen in experimental myocardial infarct].

  Kipshidze NN, Kikawa GM. Kipshidze NN, et al. Acta Cardiol. 1974;29(3):185-202. Acta Cardiol. 1974. PMID: 4135425 French. No abstract available.
• [Treatment of coronary insufficiency by carbocromen (apropos of 40 cases)].

  Queneau P, Le Guyader J, Pont M. Queneau P, et al. Rev Lyon Med. 1967 Nov 30;16(18):753-7. Rev Lyon Med. 1967. PMID: 5621963 French. No abstract available.
• [Intervention in ischemic heart disease and myocardial infarction. 3. Medical intervention].

  Pedersen A. Pedersen A. Ugeskr Laeger. 1982 Jul 19;144(29):2156-64. Ugeskr Laeger. 1982. PMID: 6128809 Review. Danish. No abstract available.
• Comparison of therapeutic effects of coronary drugs in the USSR.

  Simonson E, Berman R. Simonson E, et al. Am Heart J. 1971 Nov;82(5):684-6. doi: 10.1016/0002-8703(71)90339-5. Am Heart J. 1971. PMID: 4940222 Review. No abstract available.